항원 85 복합체를 과발현하는 재조합 BCG의 개발 및 마우스 모델에 있어서의 결핵균 감염에 대한 방어 효능
Tuberculosis (TB) remains an enormous global health problem, and a new vaccine against TB more potent than the current inadequate BCG vaccine is urgently needed. We constructed three recombinant Mycobacterium bovis BCG (rBCG) strains over-expressing antigen (Ag) 85A, Ag85B, or both of M. tuberculosi...
Gespeichert in:
Veröffentlicht in: | Tuberculosis and respiratory diseases 2004-08, Vol.57 (2), p.125-131 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | kor |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!